Roger Wetli appointed Chief Financial Officer

NovaGo Therapeutics AG announced that Roger Wetli was appointed Chief Financial Officer of the company, effective January 1, 2024. Roger leads the finance and accounting organization and reports directly to Stefan Moese, CEO.

Prior to joining NovaGo, Roger Wetli was Senior Director Tax and Finance at Neurimmune AG. His responsibilities span financial planning, reporting, controlling, treasury and tax strategy. He started his career at big-four consulting firms with a focus on international tax planning, and holds an MBA in Finance from the University of Zurich together with a diploma as a certified Swiss tax expert.

“As we intensify our outreach to additional investors for NovaGo, we are very pleased to welcome such an experienced colleague to our management team,” commented Stefan Moese, CEO.